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In the present study the effect of capsaicin was studied on PD model flies expressing human alpha synu-
clein. First the potential of scavenging superoxide anion and free radicals by capsaicin at doses of 20, 40, 
80 and 100 µM was estimated. The PD flies were allowed to feed separately on the diet containg 20, 40, 
80 and 100 µM of capsaicin, respectively, for 24 days. After 24 days of exposure, fly head homogenate 
was prepared from each group and was used to estimate glutathione (GSH), protein carbonyl (PC), dopa-
mine content, lipid peroxidation (LPO), glutathione-S-transferase (GST) and monoamine oxidase (MAO) 
activity. A dose dependent significant increase in the potential of scavenging superoxide anions and free 
radicals by capsaicin was observed for the doses of 20, 40, 80 and 100 µM. The exposure of capsaicin 
not only significantly increased the GSH (max. by 1.37-fold), and dopamine (max. by 1.56-fold) content 
but also reduced LPO (max. by 1.8-fold), GST (max. by 1.26-fold), MAO activities (max. by 1.60-fold) 
and PC content (max. by 1.95-fold), compared to unexposed PD flies (p < 0.05). The results suggest the 
protective role of capsaicin against the PD symptoms.
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INTRODUCTION
Parkinson’s disease (PD) is a neuropathological disorder involving the degeneration 
of dopaminergic neurons in the substantia nigra pars compacta of the mid-brain [2]. 
Most of the cases of PD are idiopathic since their cause is unknown. Epigenetic fac-
tors that mediate mitochondrial dysfunction, inflammation, abrogation of the autoso-
mal-lysosomal autophagy system and endoplasmic reticulum stress play a role in the 
progression of the disease [24]. It is a debilitating neurodegenerative disease charac-
terized by bradykinesia and postural instability [31]. Loss of function/mutations in 
number of genes such as α-synuclein, parkin, ubiquitin C-terminal hydrolase-1 
(UCH-1), DJ-1, phosphatase and tensin homolog (PTEN) induced kinase 1 (PINK1), 
leucin-rich repeat kinase2 (LRRK2), omi/Htr A2, ATP13A2 and glucocerebrosidase 
accounts for the late onset of sporadic PD [32]. The over expression of mutant or 
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normal form of α-synuclein lead to the formation of Lewy bodies which plays a cru-
cial role in the pathogenesis of PD [4]. The formation of Lewy bodies has been linked 
with an increased oxidative stress in the brain of PD patients oxidative stress not only 
destroys the dopaminergic neurons but also compromises mitochondrial oxidative 
phosphorylation, leading to decreased energy output and eventually to secondary 
death of cells [2]. Despite of dopamine agonists and even L-dopamine treatment none 
yet address the underlying problem associated with it, i.e. the progressive loss of 
dopaminergic neurons [34]. Various epidemiological and biochemical studies have 
recently identified promising compounds that may elicit neuroprotection in PD [24, 
28, 29]. Due to ethical reasons the experiments cannot be performed directly on 
human, hence model organisms such as mice, fruit flies and worms have been devel-
oped in order to understand the biology of the disease as well as pharmacological 
interventions [18]. A transgenic model of fruit flies expressing wild or mutant type of 
human alpha synuclein under GAL4/UAS system has been widely accepted [10]. In 
our earlier study the exposure to capsaicin has shown a delay in the loss of climbing 
ability in the same model of PD [26]. In the present study the effect of capsaicin was 
studied on the glutathione (GSH), protein carbonyl (PC) and dopamine contents, as 
well as the glutathione-S-transferase (GST) and monoamine oxidase (MAO) activi-
ties in the brain of PD model flies expressing human alpha synuclein.
MATERIALS AND METHODS
Drosophila stocks
Transgenic fly lines that express wild-type human synuclein (h-αS) under UAS con-
trol in neurons‘‘[w[*];P{w[+mC]=UAS–Hsap/SNCA.F}’’5B and GAL4 
‘‘w[*];P{w[+mC]=GAL4- elavL}’’3] were obtained from Bloomington Drosophila 
Stock Centre (Indiana University, Bloomington, IN). When the males of UAS 
(Upstream Activation Sequence)-Hsap/SNCA.F strains are crossed with the females 
of GAL4-elav. L (vice versa), the progeny expresses human αS in the neurons [10].
Drosophila culture and crosses
The flies were cultured on standard Drosophila food containing agar, corn meal, 
sugar and yeast at 25 °C (24 ± 1) [30]. Crosses were set up as described in our earlier 
published work [27]. The PD flies were allowed to feed separately on different doses 
of capsaicin (Sigma, USA) mixed in the diet. Capsaicin was added to the diet at final 
concentration of 20, 40, 80 and 100 µM for 24 days. The PD flies were also exposed 
to 10–3 M of L-dopamine. The UASHsap/SNC.F act as a control. The control flies 
were allowed separately to feed on the selected doses of capsaicin.
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Superoxide anion scavenging assay
The inhibition of nitro blue tetrazolium (NBT) reduction by phenazin methosulphate 
(PMS) generated O2
.– was used to determine the superoxide anion scavenging activ-
ity of the capsaicin [25]. The reaction mixture consisted of 75 µl of each concentra-
tion of capsaicin, 750 µl of Tris HCl (100 mM; pH 7.4); 187 µl of NBT (300 µM), 
187 µl of NADH (936 µM). The reaction was initiated by adding phenazine metho-
sulphate (PMS) (120 µM). The reaction mixture was incubated at 25 °C for 5 min and 
the OD was read at 560 nm and the degree of scavenging was calculated by the fol-
lowing equation:
Diphenyl-picrylhydrazyl (DPPH) free radical scavenging
For estimating free radical scavenging potential of the capsaicin DPPH method as 
described by Wongsawatkul et al. [33] was used in the present study. When DPPH 
(a stable purple colour) react with an antioxidant, it is reduced to yield a light yellow 
coloured diphenyl picrylhydrazine. Color change was spectrophotometrically meas-
ured. The reaction mixture consisting of 500 µl of capsaicin and 250 µl of DPPH 
(0.3 mM). The reaction mixture was shaken vigorously and allowed to stand at room 
temperature in the dark for 25 min. The OD was read at 518 nm and the radical scav-
enging activity was calculated by the following equation:
% Radical scavenging = (1 – Absorbance of sample/Absorbance of control) × 100.
Preparation of homogenate
Fly heads (50 heads) from each group (five replicates/group) were isolated and the 
homogenate was prepared in 0.1M phosphate buffer for the biochemical parameters.
Estimation of glutathione content
The glutathione (GSH) content was estimated colorimetrically using Ellman’s reagent 
(DTNB) according to the procedure described by Jollow et al. [14]. The supernatant 
was precipitated with 4% sulphosalicyclic acid (4%) in the ratio of 1 : 1. The samples 
were kept at 4 °C for 1 h and then subjected to centrifugation at 5000 rpm for 10 min 
at 4 °C. The assay mixture consisted of 550 µl of 0.1M phosphate buffer, 100 µl of 
supernatant and 100 µl of DTNB. The OD was read at 412 nm and the results were 
expressed as µ moles of GSH/gram tissue.
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Estimation of glutathione-S-transferase activity
The glutathione-S-transferase (GST) activity was determined by the method of Habig 
et al. [11]. The reaction mixture consist of 500 µl of 0.1M phosphate buffer, 150 µl 
of 10 mM CDNB, 200 µl of 10 mM reduced glutathione and 50 µl of supernatant. 
The OD was taken at 340 nm and the enzyme activity was expressed as µ moles of 
CDNB conjugates/min/mg protein.
Lipid peroxidation assay 
Lipid peroxidation was measured according to the method described by Ohkawa et 
al. [19]. The reaction mixture consisted of 5 µl of 10 mM butyl-hydroxy toluene 
(BHT), 200 µl of 0.67%, thiobarbituric acid, 600 µl of 1% O-phosphoric acid, 105 µl 
of distilled water and 90 µl of supernatant. The mixture was incubated at 90 °C for 
45 min and the OD was measured at 535 nm. The results were expressed as µ moles 
of TBARS formed/h/gram tissue.
Estimation of protein carbonyl content (PCC)
The PC content was estimated according to the protocol described by Hawkins et 
al. [12]. The brain homogenate was diluted to a protein concentration of approx. 
1 mg/ml. About 250 µl of each diluted homogenate was taken in eppendorf centrifuge 
tubes separately. To it 250 µl of 10 mM 2,4-dinitrophenyl hydrazine (dissolved in 
2.5M HCl) was added, vortexed and kept in dark for 20 min. About 125 µl of 50% 
(w/v) trichloroacetic acid (TCA) was added, mixed thoroughly and incubated at 
–20 °C for 15 min. The tubes were then centrifuged at 4 °C for 10 min at 9000 rpm. 
The supernatant was discarded and the pellet obtained was washed twice by ice cold 
ethanol: ethyl acetate (1:1). Finally, the pellets were re-dissolved in 1 ml of 6M 
guanidine hydrochloride and the absorbance was read at 370 nm.
Estimation of monoamine oxidase (MAO)
The method described by McEwen [17] was used to estimate the monoamine oxidase 
activity. The assay mixture consisted of 400 µL of 0.1M phosphate buffer (pH 7.4), 
1300 µL of distilled water, 100 µL of benzylamine hydrochloride and 200 µL of brain 
homogenate. The assay mixture was incubated for 30 min at room temperature and 
then 1 mL of 10% perchloric acid was added and centrifuged at 1500 g for 10 min. 
The OD was taken at 280 nm.
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Dopamine content determination
Dopamine content was measured by the method described by Schlumpf et al. [23]. 
Fifty heads of flies (5 replicates/group) from each group were taken in 500 µl of HCl-
butanol (0.85 ml of 37% HCl in 1 litre n-butanol). After homogenization the samples 
were centrifuged at 3000 rpm for 5 min. After collecting the supernatant, 250 µl of 
heptane and 100 µl of 0.1 M HCl were added. The samples were vortexed and cen-
trifuged at 3000 rpm for 5 min. The upper organic phase was discarded and the lower 
aqueous phase was kept for dopamine assay. To 100 µl of aqueous phase, 50 µl 0.4M 
HCl, 100 µl of sodium acetate buffer (pH 6.9), 100 µl of iodine solution was added 
and kept for two min. The reaction was stopped by adding of 100 µl of sodium sul-
phite solution. After two min, 100 µl of acetic acid (10M) was added and then the 
mixture was heated at 100 °C for 6 min. The OD was taken at 375 nm after cooling 
the samples at room temperature.
Statistical analysis
The statistical analysis was done by using one-way ANOVA.
RESULTS AND DISCUSSION
A dose dependent significant increase in the potential of scavenging superoxide anion 
(Fig. 1A) as well as free radicals (Fig. 1B) was observed for each of the selected doses 
of capsaicin. Oxidative stress is a major factor for the pathogenesis of PD, especially 
due to the death of dopaminergic neurons [20]. Natural plant products have a variety 
of biological activities and also have potential to influence pathogenesis of neurode-
generative disease [16]. The mechanisms responsible for neurodegeneration in PD are 
largely unknown, although researches have suggested that mitochondrial complex 
dysfunction, oxidative stress and abrupt proteolytic degradation may also contribute 
to the pathogenesis of the disease [32]. GSH is the most abundant thiols present in the 
Fig. 1. (A) Superoxide anion scavenging activity of capsaicin and (B) Radical scavenging activity of 
capsaicin. The values are the mean of five assays [*significant with respect to control, p < 0.05]
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eukaryotic cells. The depletion in the content of GSH is an indication of cytotoxici-
ty [13]. The results obtained for the GSH content showed a significant 1.61-fold of 
decrease in the GSH content (Fig. 2A; p < 0.05). The exposure of PD flies to 20, 40, 
80 and 100 µM of capsaicin showed a dose dependent significant increase of 1.20-, 
1.28-, 1.35-, 1.37-folds in the GSH content compared to unexposed PD flies (Fig. 2A; 
p < 0.05, r = 0.971). GSTs are enzymes responsible for the detoxification and hence 
an increased GST activity indicates a state of oxidative stress [15]. The GST activity 
showed a significant increase of 1.76-fold compared to control flies (Fig. 2B; 
p < 0.05). The exposure of PD flies to 20, 40, 80 and 100 µM of capsaicin, respec-
tively, showed a dose dependent significant decrease of 1.04-, 1.12-, 1.20-, 1.26-folds, 
respectively in GST activity (Fig. 2B; p < 0.05, r = –0.987). Glutathione, a tripeptide, 
is responsible for hydrophilic xenobiotics conjugation. The sulphydryl group is 
essential for its antioxidant activity against some forms of reactive oxygen species 
(ROS) in cells [9]. There are evidences that natural plant products can increase the 
intracellular basal level of GSH in order to combat the generation of free radicals [6]. 
The generated free radicals can attack unsaturated lipids in a cell, resulting in a chain 
reaction of the formation of free radicals [9]. The end products of this reaction are 
lipid alcohols, aldehydes and malondialdehyde (MDA). Therefore the measurement 
of the MDA is a common method for the toxicological evaluation [9]. The PD flies 
showed an increase of 2.4-fold in the lipid peroxidation compared to control flies 
(Fig. 2C; p < 0.005). The PD flies exposed to 20, 40, 80 and 100 µM of capsaicin 
Fig. 2. (A) Effect of capsaicin on the glutathione (GSH), (B) glutathione-S-transferase (GST) activity, 
(C) Lipid peroxidation and (D) Protein carbonyl content in the brains of flies [C1 = 20 µM; C2 = 40 µM; 
C3 = 80 µM; C4 = 100 µM; PD = PD flies; Dopamine = 10–3M; N = 50 heads]. The flies were allowed to 
feed on the diet supplemented with capsaicin for 24 days and then assayed for GSH content. [asignificant 
difference with respect to control, p < 0.05; bsignificant difference with respect to PD flies p < 0.05]
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showed a dose dependent significant decrease of 1.16-, 1.33-, 1.63-, 1.8-folds in lipid 
peroxidation compared to unexposed PD flies (Fig. 2C; p < 0.05, r = –0.9925). The 
PD flies showed a significant increase of 2.68-fold in the PC content compared to 
control flies (Fig. 2D; p < 0.05). The PD flies exposed to 20, 40, 80 and 100 µM of 
capsaicin, respectively, showed a dose dependent significant decrease in the PC con-
tent of 1.22-, 1.43-, 1.65-, 1.95-folds compared to unexposed PD flies (Fig. 2D; 
p < 0.05, r = –0.9851). In our present study the PD flies showed an increase in LPO, 
PC content, GST activity and decrease in GSH content, however, the exposure of PD 
flies to capsaicin resulted in a decrease in LPO, PC content, GST activity and increase 
in GSH content in a dose dependent manner. Reactive intermediates can react with 
GSH either by a direct chemical reaction or by a GST mediated reaction preventing 
the possible cell death. Capsaicin has been reported to scavenge free radicals and 
reduced the lipid peroxidation in rat brain homogenate thus proving its implication in 
the prevention or treatment of neurodegenerative disease [7]. It also reduced 
Alzheimer associated tau changes in the hippocampus of type 2 diabetes rats [35]. In 
our study the PD flies showed an increase levels of MAO but flies exposed to cap-
saicin showed a decrease in the activity MAO in a dose dependent manner. The PD 
flies showed a significant increase of 4.42-fold in the activity of MAO (Fig. 3A; 
p < 0.05). The PD flies exposed to 20, 40, 80 and 100 µM of capsaicin, respectively, 
showed a dose dependent significant decrease of 1.09-, 1.24-, 1.47-, 1.60-folds in 
MAO activity, compared to unexposed PD flies (Fig. 3A; p < 0.05, r = 0.991). MAO 
is an iron containing enzyme that has been reported to maintain the neuron firing rate 
and is also involved in the metabolism of dopamine [8]. Our results obtained on 
superoxide anion and free radical scavenging assays performed on the selected doses 
of capsaicin showed that it has a potential of scavenging free radicals and superoxide 
anions. Hence, its antioxidant potential may contribute to recover the impaired func-
tions of PD flies. The balance between oxidation and anti-oxidation is believed to be 
critical in maintaining healthy biological systems. Under normal conditions, the anti-
oxidant defense system allows the elimination of excess ROS, including superoxide 
anions and free radicals [3].
Our present findings also suggest an increase in the dopamine content in the brain 
of PD flies exposed to capsaicin. The PD flies showed a significant decrease of 2.08-
fold in the dopamine content, compared to control flies (Fig. 3B; p < 0.05). The PD 
flies exposed to 20, 40, 80 and 100 µM of capsaicin showed a dose dependent sig-
nificant increase of 1.23-, 1.39-, 1.51-, 1.56-folds in the dopamine content compared 
to unexposed PD flies (Fig. 3B; p < 0.05, r = 0.97). Pathologically, PD is character-
ized by the degeneration of dopaminergic neurons in the substantia nigra pars com-
pacta that leads to the depletion of dopamine [21]. In our study the exposure of PD 
flies to capsaicin leads to an increase of the dopamine content. Capsaicin has been 
reported to prevent the degeneration of dopamine neurons by inhibiting glial activa-
tion and oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 
mouse model of PD [5]. Our earlier studies on the PD model flies demonstrated that 
the exposure of flavonoid protects the dopaminergic neurons [1], and the study with 
geraniol on mice also suggests that the natural plant products are effective in protect-
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ing the dopaminergic neurons and thereby results in maintaining the appropriate 
levels of dopamine [22]. However, our earlier study with geraniol showed that it does 
not alter the expression of α-synuclein and the formation of Lewy bodies, but its 
antioxidant potential is responsible for delaying the PD symptoms in the PD model 
flies [29]. It is concluded that capsaicin is potent in recovering the impaired functions 
of PD flies.
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Fig. 3. (A) Effect of capsaicin on the monoamine oxidase activity and (B) Dopamine content measured 
in the brains of flies [C1 = 20 µM; C2 = 40 µM; C3 = 80 µM; C4 = 100 µM; PD = PD flies; 
Dopamine = 10–3M; N = 50 heads]. The flies were allowed to feed on the diet supplemented with capsa-
icin for 24 days and then assayed for monoamine oxidase activity. [asignificant difference with respect to 
control, p < 0.05; bsignificant difference with respect to PD flies p < 0.05] 
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